FDA approves Akebia anemia pill, two years after rejection
BioPharma
Source: biopharmadive.com
Amgen Epogen News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Amgen Epogen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Amgen Epogen Today - Breaking & Trending Today
BMS Cancer Drug's New FDA Nod Puts It on Path to Reach Blockbuster Status
Bristol Myers Squibb drug Reblozyl is now approved as a first-line therapy for anemia caused by myelodysplastic syndromes, a group of blood cancers. It’s the third indication for the drug, which analysts project could top $4 billion in peak sales.
Source: medcitynews.com
Managing 3rd Party IP and Freedom to Operate in Drug Development | Procopio, Cory, Hargreaves & Savitch LLP
When it comes to product development, the management of third-party intellectual property (IP) to ensure freedom to operate is of paramount importance. Drug development is no different....
Source: jdsupra.com
Flagship Startup Emerges to Find Drugs in Promising Hunting Ground—Our Bodies
Scientists at Empress Therapeutics say molecules that co-evolved with humans over millennia are a promising source of new drugs. With its AI-driven technology platform, the Flagship Pioneering-founded startup finds them.
Source: medcitynews.com